An Open-label Trial of Clevidipine for Controlled Hypotension During Spinal Fusion
Completed · Phase 2/Phase 3
Conditions studied: Neuromuscular Scoliosis
In brief
The current study would prospectively evaluate the dosing requirements, efficacy and safety of clevidipine for controlled hypotension during spinal surgery in the pediatric population. As the investigators currently have projects underway which include those patients having scoliosis surgery for idiopathic scoliosis, this trial would include only those undergoing scoliosis surgery for neuromuscular disease.
Key facts
- Study ID
- NCT01645111
- Run by
- Nationwide Children's Hospital
- People needed
- 50
- Starts
- 2012-06-01
- Expected to finish
- 2013-12-01
- Last updated by the study team
- 2015-02-18
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Spinal fusion for neuromuscular scoliosis.
You may not qualify if…
- Allergy to dihydropyridine calcium channel antagonists
- Allergy to soy or eggs
- Non-neuromuscular causes of scoliosis
- Disorders of lipid metabolism (clevidipine is in a lipid base)
Where it is running
- Nationwide Children's Hospital — Columbus, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.